170
Views
1
CrossRef citations to date
0
Altmetric
Articles

Two new stilbene glucosides and a new benzoic acid derivative from Tournefortia sibirica

, , , ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon show all
Pages 746-753 | Received 28 Jul 2020, Accepted 17 Sep 2021, Published online: 09 Feb 2022
 

Abstract

Two new stilbene glucosides, trans-3,5-dihydroxy-4-methoxystilbene 3-O-β-D-glucopyranoside (1), cis-3,5-dihydroxy-4-methoxystilbene 3-O-β-D-glucopyranoside (2), one new benzoic acid derivative, cis-4-hydroxy-3-hydroxymethyl-2-butenyl benzoate 4-O-β-D-glucopyranoside (3), and four known compounds (4 − 7) were isolated from Tournefortia sibirica L. The structures of these compounds were elucidated on the basis of spectral data. Anti-inflammatory effects of compounds (1 − 7) were evaluated in terms of inhibition on production of NO, TNF-α and IL-6 in LPS-induced RAW 264.7 cells. Compounds 1, 2 and 5 − 7 could inhibit the levels of NO, TNF-α and IL-6 in LPS-induced RAW264.7 cells with IC50 values ranging from 40.96 to 88.76 µM.

Graphical Abstract

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This research was financially supported by the National Natural Science Foundation of China (No. 81760627). This research was also financially supported by the Department of Science & Technology of Jilin Province (No. 20200201034JC), Education Department of Jilin Province (No. JJKH20200534KJ), and Administration of traditional Chinese Medicine of Jilin Province (No. 2020140).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.